Show simple item record

dc.contributor.authorHendrawati, Asri
dc.date.accessioned2019-03-25T02:43:40Z
dc.date.available2019-03-25T02:43:40Z
dc.date.issued2017-04-27
dc.identifier.urihttp://hdl.handle.net/123456789/14323
dc.descriptionCollections > Lecturers > Faculty of medicine > POSTERen_US
dc.description.abstractType 2 diabetes mellitus is a metabolic disease that often cause cardiomyopathy and heart failure. These complications are caused by free radicals increasing that induced expression of pro inflammatory genes nuclear factor kappa B (NF-KB) and causes cells damage. Quercetin is an antioxidant that can affect the expression of NF-KB and prevent cells damage. The combination of quercetin with oral hypoglycaemic drugs is expected to be a better therapy for type 2 diabetes. The aim of this study is to measure the effects of quercetin and glibenclamide combination on cardiac muscle cells NF-KB expression in type 2 diabetic rats compared with no combination.en_US
dc.language.isoen_USen_US
dc.publisherSICEMen_US
dc.subjectdiabetes mellitus, quercetin, glibenclamideen_US
dc.titleEFFECT OF QUERCETIN AND GLIBENCLAMIDE COMBINATION ON CARDIAC MUSCLE NUCLEAR FACTOR KAPPA B (NF-KB) EXPRESSION IN TYPE 2 DIABETIC RATSen_US
dc.typeOtheren_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record